文献速递流行病学与生物统计基础与转化研究

中位生存时间的逆方差加权Meta分析方法

Meta-Analysis of Median Survival Times With Inverse-Variance Weighting.
PubMed 文献 · Stat Med · 2026-01-01

针对中位生存时间Meta分析中研究内标准误常未报告的问题,提出从已报告置信区间估计标准误的逆方差加权方法。模拟研究表明,当研究内样本量中等(如>50)时,该方法与使用真实标准误的基准方法性能相近;样本量小时标准误估计可能有偏。该方法在非小细胞肺癌随机试验生存获益Meta分析中进行了应用展示。

要点

  • 中位生存时间Meta分析可从置信区间反推研究内标准误。
  • Brookmeyer-Crowley法构建的置信区间下该方法标准误估计一致。
  • 研究内样本量>50时性能与真实标准误基准方法相近。

核心结论

  • 基于置信区间估计研究内标准误的逆方差加权法可用于中位生存时间Meta分析。
  • 研究内样本量中等以上时该方法与真实标准误基准方法性能相近。
  • 有效样本量小时研究内标准误估计可能存在偏倚。

研究设计与样本

  • 方法学文章,提出逆方差加权方法并从报告置信区间估计研究内标准误。
  • 开展系列模拟研究评估研究层面和Meta分析层面的性能。
  • 以非小细胞肺癌随机试验生存获益Meta分析作应用示例。

主要发现

  • 对Brookmeyer-Crowley法构建的置信区间,该方法一致估计中位生存标准误。
  • 研究内样本量中等(如>50)时与真实标准误基准方法性能相近。
  • 有效样本量小时研究内标准误估计可能有偏。
  • 模拟评估覆盖合并中位数、中位数差和中位数比等指标。

关键数值与推荐

  • 研究内样本量中等(如>50)时方法性能与基准方法相近。
  • 有效样本量小时研究内标准误估计可能偏倚。

临床怎么用

  • 当原始研究仅报告中位生存时间及置信区间时,可用该方法进行逆方差加权Meta分析。
  • 应用时需关注研究内有效样本量,样本量小时对标准误估计保持谨慎。

局限性

  • 有效样本量小时研究内标准误估计可能存在偏倚。
  • 方法一致性结论仅针对Brookmeyer-Crowley法构建的置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We consider the problem of meta-analyzing outcome measures based on median survival times. Primary studies with time-to-event outcomes often report estimates of median survival times and confidence intervals based on the Kaplan-Meier estimator. However, outcome measures based on median survival are rarely meta-analyzed, as standard inverse-variance weighted methods require within-study standard errors that are typically not reported. In this article, we consider an inverse-variance weighted approach to meta-analyze median survival times that estimates the within-study standard errors from the reported confidence intervals. We show that this method consistently estimates the standard error of median survival when applied to confidence intervals constructed by the Brookmeyer-Crowley method. We conduct a series of simulation studies evaluating the performance of this approach at the study level (i.e., for estimating the standard error of median survival) and the meta-analytic level (i.e., for estimating the pooled median, difference of medians, and ratio of medians) for commonly used confidence intervals for median survival, including the Brookmeyer-Crowley method and nonparametric bootstrap. We find that this approach often performs comparably to a benchmark approach that uses the true within-study standard errors for meta-analyzing median-based outcome measures when within-study sample sizes are moderately large (e.g., above 50). However, when the effective sample sizes are small, the method can yield biased estimates of within-study standard errors. We illustrate an application of this approach in a meta-analysis evaluating survival benefits of being assigned to experimental arms versus comparator arms in randomized trials for non-small cell lung cancer therapies.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. McGrath S, Yang CH, Kimmelman J, et al. Meta-Analysis of Median Survival Times With Inverse-Variance Weighting. Stat Med. 2026. PMID: 41998861. doi:10.1002/sim.70533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。